Impact of prospective measurement of outflow tracts in the prediction of coarctation of the aorta by Vigneswaran, T. V. et al.
This article has been accepted for publication and undergone full peer review but has not been 
through the copyediting, typesetting, pagination and proofreading process which may lead to 
differences between this version and the Version of Record. Please cite this article as doi: 
10.1002/uog.21957 
 
 Impact of prospective measurement of outflow tracts in the 
prediction of coarctation of the aorta  
 
Trisha V Vigneswaran MBBS MRCPCH1,2,3, Vita Zidere MD FRCP1,2, Sian Chivers MB ChB 
MRCPCH2, Marietta Charakida MD PhD1,2,3, Ranjit Akolekar MD MRCOG1,4  , John M Simpson MD 
FRCP1,2,3 
 
1Harris Birthright Centre, Fetal Medicine Research Institute, King’s College Hospital, Denmark Hill, 
London, SE5 9RS, UK. 
2 Department of Congenital Heart Disease, Evelina London Children’s Hospital, Guy’s & St Thomas’ NHS 
Trust, Westminster Bridge Road, London SE1 7EH, UK. 
3 Department of Biomedical Engineering, King’s College Hospital, London SE1 7EH, UK. 
4 Department of Obstetrics & Gynaecology, Medway Maritime Hospital, Kent ME7 5NY, UK. 
 
Corresponding author: Dr Trisha Vigneswaran, Department of Congenital Heart Disease, Evelina 
London Children’s Hospital, Guy’s & St Thomas’ NHS Trust, Westminster Bridge Road, London SE1 
7EH, UK. Email: trisha.vigneswaran@gmail.com  
Short title: COA measurements, Vigneswaran 
Keywords: coarctation of the aorta, aortic isthmus, arterial duct, z score, bicuspid aortic valve, fetus, 
congenital heart disease 




What are the novel findings of this work? 
 
1. Risk equations for prediction of coarctation of the aorta are derived. They can be used to 
aatribute a risk of coarctation of the aorta (COA) according to specific measurements in a fetus. 
 
2. There is a higher than expected prevalence of bicuspid aortic valve in patients who were 
suspected, but not proven to have COA. 
 
What are the clinical implications of this work? 
 
Measurement of the distal transverse aortic arch and the arterial duct should be routinely included 
in assessment of fetuses with COA and may improve accuracy of prenatal diagnosis 
 
Parents should be counselled regarding the possibility of a bicusid aortic valve and the implications 
of this even in the absence of aortic stenosis in the fetus




Background: Prenatal diagnosis of coarctation of the aorta (COA) is associated with reduced mortality and morbidity, 
however, accurate prenatal prediction remains challenging. To date, studies have measured the outflow tracts 
retrospectively to gauge the potential to predict COA. Our primary objective was to evaluate prospectively acquired 
measurements of the outflow tracts in prenatally suspected COA. A secondary aim was to report the postnatal 
prevalence of bicuspid aortic valve in this cohort. 
Methods: Measurement of the aortic valve, pulmonary valve, distal transverse aortic arch (DTAA) and arterial duct 
(AD) diameters were undertaken routinely in fetuses with suspected COA between 2002–2017. Using published 
reference ranges based on >7000 fetuses from our own unit, z scores were computed.  
Results: COA was confirmed after birth in 77/149 (52%) cases. DTAA z score and the z score of DTAA:AD were 
smaller in cases with confirmed COA compared to false positive (FP) (-2.8 vs -1.9, p=0.039; -3.13 vs -2.61, p=0.005, 
respectively). Multiple regression analysis demonstrated that z scores of DTAA and AD were the only significant 
predictors (p=0.001). Bicuspid aortic valve was identified in 30% of the FP group. 
Conclusion: Measurement of the DTAA and AD z scores can be used to attribute risk for postnatal COA in a selected 
cohort. The significance of the high incidence of bicuspid aortic valve in FP cases merits further study both with 








Prenatal diagnosis of coarctation of the aorta (COA) is associated with reduced morbidity,1 but it continues 
to be a difficult form of major congenital heart disease to diagnose with accuracy before birth.2 Unlike other 
forms of congenital heart disease, it is associated with a significant false positive diagnosis rate of up to 
69%.3-6 The prenatal diagnosis of COA is suspected when there is asymmetry of the ventricles and/or great 
arteries with hypoplasia of the aortic arch (figure 1). Studies investigating the impact of measurement of 
left heart structures to improve the diagnostic accuracy of COA have all been retrospective 6-9 apart from a 
single prospective study which  included less than 40 cases;10 thus a recent meta-analysis  emphasised the 
need for larger prospective studies.6  
At our unit, measurement of the relevant cardiac structures have been made routinely by experienced fetal 
cardiologists permitting evaluation of measurements made at the time of clinical assessment. Furthermore, 
z scores of the size of the great arteries and aortic arch using data from over 7000 cases have been published 
recently. This  provided an opportunity to investigate the value of measurements made prospectively as part 
of standard clinical care to predict COA using suitable z scores.11 A further objective of the study was to 
document the incidence of bicuspid aortic valve in this cohort.  
 
 




Cases of COA suspected by a fetal cardiologist were identified from the cardiac database at the Harris Birth 
Right Research Centre for Fetal Medicine, King’s College Hospital, UK. This is a tertiary fetal cardiology 
centre in the United Kingdom. Fetuses were included if the main cardiac connections were normal and the 
attending fetal cardiologist had requested postnatal echocardiography to confirm or refute COA. 
Echocardiograms performed between 15-36 weeks gestational age were identified between January 2002 
and December 2017. The study population comprised suspected cases of isolated COA with a minimum of 
six months postnatal follow-up to allow for later evolution/presentation of COA.4  Cases of COA with a 
VSD and/or persistent left superior vena cava were also included.  Exclusion criteria were: co-existent 
forms of major congenital heart disease (CHD) e.g. transposition of the great arteries, lesions causing 
abnormal cardiac loading e.g.  direct connection of the umbilical vein to the right atrium and pregnancies 
which resulted in termination, miscarriage or stillbirth. Information about karyotype, nuchal translucency, 
extracardiac anomalies and outcome was recorded. The endpoint was surgery for COA within the first six 
months after birth. The decision to initiate prostaglandin E2 or not immediately after birth was made by the 
attending fetal cardiologist based on the findings at the last fetal echocardiogram. In all cases, the initial 
postnatal echocardiogram was reviewed and a decision made either to continue prostaglandin E2 if the 
findings supported a diagnosis of COA or else to observe the baby off prostaglandin E2 with serial clinical 
and echocardiographic assessment to look for signs of evolving coarctation. The monitoring included four 
limb blood pressure, clinical review of femoral pulses and measurement of serum lactate.  The standard 
features of postnatal COA were applied including echocardiographic features of flow acceleration at the 
site of coarctation and loss of pulsatility of the descending aorta. Once clinical or echocardiographic signs 
of COA emerged then prostaglandin E2 was commenced, and surgery was scheduled. Data on pregnancy 
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outcome was ascertained from electronic records or patient contact in all women who underwent prenatal 
ultrasound. Children suspected to have heart disease at the postnatal assessment or community checks are 
referred to our paediatric cardiac service and therefore cases of congenital heart disease which were missed 
on routine prenatal screening or specialist fetal echocardiography in our unit would be identified. 
 
Echocardiographic Measurements 
All measurements were made on cart at the time of the fetal echocardiogram by one of a team of fetal 
cardiologists and these measurements were retrieved from the archived echocardiogram reports. Thus, the 
outcome was not known at the time of measurement. When several echocardiographic examinations were 
available for an individual patient, the dataset closest to 20 weeks gestation was used to compute z scores 
as the decision regarding site of delivery was made at this gestation. For assessment of the arterial duct, 
analysis was performed on echocardiograms <28 weeks gestation in view of the possible impact of an 
aneurysmal or tortuous arterial duct which can be present in the third trimester. Measurements were taken 
as previously described11: the aortic and pulmonary valve were measured in diastole at the maximal 
diameter with the valve closed and the distal transverse aortic arch diameter (DTAA) and arterial duct (AD) 
were measured in the 3 vessel and tracheal (3VT) view (figure 2). The outflow tract measurements were 
converted into gestational age-adjusted z scores using previously published departmental data based on 
prospectively collected measurements from a population of over 7000 fetuses with a normal outcome.11 
Echocardiograms were performed using the Acuson Aspen Advanced (Acuson, Mountain View, CA) with 
a 4 to 7 MHz curvilinear probe or a Voluson E8 (GE Medical Systems, Zipf, Austria) with a 4 to 8 MHz or 
6 MHz curvilinear probe or a Toshiba Aplio 500 (Canon Medical Systems, Europe) with a 10MHz or 6 
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MHz appropriate to the gestational age. Postnatal echocardiograms undertaken after the year 2010 
(availability of digital echocardiogram archive) were reviewed to ascertain aortic valve morphology.  
 
Statistical analysis 
Comparison of the two groups according to the outcome measure of operated COA within 6 months of birth 
was performed. Median values were calculated for all cardiac parameters and analysed using the Mann 
Whitney test. The performance of test variables was determined using receiver operating characteristic 
(ROC) curves analysis and logistic regression analysis to assess contribution of cardiac parameters (z scores 
of aortic valve, pulmonary valve, arterial duct, DTAA and AD:DTAA, aorta:pulmonary ratio) to prediction 
of postnatal COA. The statistical software package SPSS 24.0 for MAC (SPSS Inc.,Chicago, IL, USA) and 
Prism 7.0 for MAC (GraphPad software Inc.,CA, USA) was used for data analyses. Analysis of this data 
acquired for clinical reasons was approved by United Kingdom Health Research Authority (reference 
no:19/HRA/1096).   
 




There were 294 pregnancies with suspected COA, of which 171 continued, 93 cases were terminated due 
to major extracardiac abnormalities, chromosomal anomaly or for the potential for progression to single 
ventricle circulation. Thirty pregnancies ended in spontaneous intra-uterine death/stillbirth, 17 cases were 
born in other countries and 3 babies died in the neonatal period.  In two cases measurement of the aortic 
and ductal arch measurements were not performed. Thus, 149 pregnancies were included in this study of 
whom 77 (52%) were confirmed to have COA within six months of age. The indications for fetal 
echocardiography were: suspected CHD (n=113), extracardiac anomalies (n=11), family history of CHD 
(n=5), nuchal translucency >95th centile (n= 20). Two of the fetuses with a family history had paternal 
history of COA repair. The karyotype was tested prenatally in 73/149 patients and chromosomal/genetic 
syndromes were identified in 20/149 (15%) patients with: 45XO (n=5), trisomy 21 (n=3), mosaic 45 X0/XY 
(n=1), microdeletion chromosome 22q11 (n=1), balanced duplications (n=2), 47-XXY (n=1), Coffin-Siris 
syndrome (n=1), Kabuki syndrome (n=1), Cornelia De Lange (n=1), 13q deletion (n=1),  VACTERL (n=1), 
CHARGE (n=1) and Russell Silver (n=1). The morphology of the aortic valve was identified as bicuspid 
after birth in 34/60 (57%) of the true COA group and 18/59 (30%) of the false positive group (p=0.04).   
 
Outcome 
The true positive rate of diagnosis of COA was 77/149 (52%) of which 74/149 (49.7%) were diagnosed in 
the neonatal period and 3/149 (2%) beyond the neonatal period at 5 weeks, 9 weeks and 6 months after 
birth. There were no known cases of COA which were overlooked on specialized fetal echocardiography 
or with routine ultrasonography from Kings College Hospital during the study period.  True and false 
positive cases did not differ with respect to gestational age at echocardiogram nor the presence of a 
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persistent left superior vena cava. A ventricular septal defect (VSD) was present in both true and false 
positive cases, but was seen more commonly in those with confirmed COA (table 1). The ratio of the 
aortic:pulmonary valve diameter, DTAA diameter, second trimester ratio of DTAA:AD were significantly 
smaller in fetuses with confirmed COA (supplementary table 1, supplementary figure 1). With reference to 
the computed z scores, the aortic valve z score, DTAA z score and second trimester z score of the ratio of 
DTAA:AD were significantly different between the two groups. No abnormal cardiac, genetic or 
extracardiac findings were identified after birth in 31/72 (43.1%) cases in the false positive cohort.  
 
Logistic regression analysis demonstrated that DTAA z-score and arterial duct z-score were the only 
predictive variables. The model explained 18% (Nagelkerke R2) of the variance of outcome and correctly 
classified 63% of cases.  The calculated equation was as follows:  
y=-1.54+(-0.559*DTAA z score) + (0.303*AD z score). Other echocardiographic parameters, gestational 
age at scan, presence of left SVC, aortic valve morphology, presence of VSD were not predictive.   Thus, 
the patient-specific risk for COA can be calculated from the formula: Risk = odds / (1+ odds) where odds 
= eY.  
 
Predictive variables for COA 
Echocardiographic parameters were further assessed for their predictive value using area under the receiver 
operating characteristics (AUROC) curve (table 3). The sensitivity, specificity, positive predictive value 
and negative predictive values are provided for DTAA z scores in table 4.  
 
 




When COA is suspected prenatally, a series of observations and repeated investigations are needed 
postnatally to confirm or refute the diagnosis whilst the arterial duct constricts. A false diagnosis has a 
psychological impact on the parents12 and creates mother-baby separation in the immediate newborn period. 
In addition to this unnecessary hospitalization, there is the financial impact of neonatal admission to monitor 
for evolution of a coarctation.13  
In our assessment of fetuses seen in a fetal cardiology unit and suspected to have COA we have 
demonstrated that the DTAA z score and the ratio of DTAA:AD z score are smaller in fetuses with 
confirmed COA. The DTAA z score and the AD z score demonstrate predictive value for COA. Despite 
the introduction of biometric assessment at the time of prenatal diagnosis the background false positive rate 
is approximately 50%. Our data shows that computation of both the DTAA and AD z scores can lead to a 
better stratification of risk which may improve parental counselling and postnatal planning.  
 
Comparison to published data 
Even in expert hands,  COA remains a challenging diagnosis to correctly ascertain prenatally as evidenced 
by the high false positive rate reported in the literature.6 The single prospective study assessing the impact 
of prenatal aortic arch measurements in the prediction of COA10 reviewed 32 cases in the third trimester 
and confirmed COA in 9. Prediction for COA was improved if ratio of the AD:aortic isthmus and an 
absolute measurement of the aortic isthmus<4.2mm were used.10 This threshold value for the aortic isthmus 
of 4.2mm is above the 50th centile at 32-36weeks gestation and in our cohort gives low specificity for the 
diagnosis (table 4). That  study10 was one of seven studies included in a recent meta-analysis to identify 
risk factors for the prenatal diagnosis of COA.6 Six studies were conducted retrospectively and each 
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included 31-85 fetuses with suspected COA. The results we present are consistent with the meta-analysis 
to the extent that a there is a smaller aortic valve and aortic isthmus in fetuses with confirmed COA 
compared to false positives. In our study, we have provided an additional risk assessment according to 
DTAA z score and AD z score which can be applied to each case to provide further information for parental 
counselling. It may also aid in planning postnatal assessment according to risk and potentially reducing 
neonatal length of stay, mother-baby separation and health care costs.13 
 
Other studies8, 14-16 recommend integration of the isthmus:AD ratio to reduce the false positive rate and our 
data using the z score of DTAA:AD ratio supports this, but demonstrates an overlap of measurements such 
that any cut-off would require compromise between diagnostic rate and diagnostic accuracy. This lack of 
clear cut-off is conceivable given that the initial criteria for diagnosis is subjective appearance of 
disproportion of the great arteries. 
 
New findings from this study 
The high incidence of bicuspid aortic valve (BAV) in COA is well recognised,17 however, the prevalence 
of BAV in the false positive cohort is reportedly low or not reported.5, 7, 10, 18-21 Our study provides novel 
data regarding the unexpectedly high prevalence of BAV (30%) in false positive cases, exceeding the 
expected population prevalence and that from other studies. The determination of aortic valve morphology 
was based on postnatal echocardiography due to the difficulty in visualisation before birth. The higher 
prevalence of BAV in our cohort may be explained by the use of arterial disproportion compared to other 
studies which only used ventricular asymmetry, a marker for non-cardiac pathology. Only two patients in 
the false positive group underwent fetal echocardiography for family history of COA/BAV and therefore, 
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is not a confounder. BAV is associated with development of dilatation of the ascending aorta with 
advancing age.  In paediatric cohorts where there is no aortic valve stenosis/regurgitation or coarctation 
gradient, the ascending aorta can remain normal.22  Common gene mutations to bicuspid valve aortopathy 
and COA such as NOTCH1, MATR3, GATA5 have been reported.23-25 However, the high incidence of 
BAV in association with hypoplasia of the aortic arch in utero without postnatal development of COA has 
not been described previously. We suggest that the potential association with BAV morphology should be 
included in prenatal counselling and that postnatal surveillance should also assess the aortic valve 
morphology given the potential consequences of aortic valve stenosis, regurgitation or aortopathy.26-29  
 
Methodological strengths of this study 
These include measurement of the outflow tracts using protocolised criteria, taken on cart at the time of the 
echocardiogram by specialist fetal cardiologists. Retrospective studies can result in a bias toward inclusion 
of cases with better image quality, and true blinding to postnatal outcome may be difficult. Secondly, the 
DTAA was measured on the 3VT view and not used interchangeably with the aortic isthmus measurements 
on sagittal views of the arch. Thirdly, calculation of z scores used our own published departmental data11 
from >7000 prospectively assessed fetuses whereas  previous studies have used z scores from a smaller 
cohort(<204) of retrospectively assessed fetuses.15 Furthermore, we have taken a consistent approach to 
assessment and our conclusions are not constrained by limitations of a meta-analysis combining studies 
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Although biometry of the great arteries is important, with transition to the neonatal circulation, an increase 
in left ventricular preload may alter the dimensions of the aortic arch. This may explain why despite a very 
small DTAA z score, the risk assessment does not reach 100%. Further refinement of prenatal diagnosis 
may be achieved with complementary physiological methods.30-36 The association of aortic arch hypoplasia 
in utero and BAV merits further study.   
 
Limitations 
Whilst measurements were taken prospectively during the fetal echocardiogram, the measurements were 
not taken with the a priori goal to test our hypothesis. Measurements were made by multiple observers and 
therefore interobserver variability may occur. Our protocol did not include routine assessment of ventricular 
size, but focused on the outflow tracts to enhance diagnosis and understanding in this region as it was 
perceived that these were the crucial areas rather than ventricular sizes.  
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Figure 1: Four chamber view and great artery views of two fetuses at 22 weeks gestation with suspected 
coarctation of the aorta. Both fetuses demonstrate ventricular asymmetry and disproportion of the great 
arteries. The fetus in panels a-c was proven to have coarctation of the aorta, whereas the fetus in panels d-
f did not require surgery for coarctation of the aorta.  [Abbreviations:  Ao – aorta, PA – pulmonary artery, 
*: superior vena cava] 
Figure 2a: The distal transverse aortic arch diameter was measured on the 3 vessel and tracheal view 
beyond the trachea at the distal point of its widest systolic diameter. 2b: The arterial duct was measured 
on the 3 vessel view at its widest systolic diameter. Both measurements are made from inner edge to inner 
edge. 
Supplementary figure 1. A: Aortic valve z score; B: Distal transverse aortic arch z score; C: 
Ratio of Distal transverse aortic arch:arterial duct z-score. [Abbreviations: COA coarctation of 
the aorta] 
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Table 1: Comparison of fetal outflow tract z scores in fetuses with neonatal coarctation of the aorta and 
false positive cases. Variables are reported as median with range or counts. Mann Whitney test to assess 
for differences between groups. * indicates there was a significant difference between the false positive and 
true COA groups. [Abbreviations: DTAA: distal transverse aortic arch, AD: arterial duct, VSD: ventricular 
septa defect] 





Median gestational age (range) in weeks 23 (19-35) 23 (15-37) 0.76 
Nuchal translucency >95th centile 12/47 13/41 0.52 
Persistent left SVC 20/72 (28%) 16/77 (21%) 0.32 
No. of patients with VSD 20/72 (28%) 34/77 (44%) 0.038* 
No. of confirmed cases of bicuspid aortic valve 18/59 (30%) 34/60 (57%) 0.004* 
Aortic valve z score -1.3 
(-4.6 to 3.8) 
-1.7 
(-4.8 to 2.9) 
0.036* 
Pulmonary valve z score 1.1 
(-4.3 to 5.2) 
1.8 
(-1.3 to 5.4) 
0.058 
DTAA z score -1.9 
(-4.0 to 3.8) 
-2.8 
(-5.5 to 0.4) 
0.039* 
Arterial duct z score (2nd trimester) 0.42 
(-1.5 to 5.2) 
0.87 
(-3.8 to 5.8) 
0.53 
Arterial duct z score (all cases) 0.4 
(-1.5 to 11.8) 
0.9 
(-3.8 to 7.9) 
0.344 
Z score of ratio DTAA:AD z score (2nd 
trimester) 
-2.61  
(-4.33 to 2.01) 
-3.13 
(-5.45 to -0.26) 
0.005 




Z score of ratio DTAA:AD z score (all cases) -2.61 
(-4.33 to 2.01) 
-3.2 
(-5.45 to 8.4) 
<0.001* 
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Table 2: Risk assessment (%) for postnatal coarctation of the aorta in fetuses with suspected COA utilizing 
the DTAA z score and arterial duct z score  
Distal transverse 
aortic arch z score  ↓ 
Arterial duct z score 
-2.0 -1.5 -1.0 -0.5 0 0.5 1.0 1.5 2.0 
DTAA z score -5.5 72 75 77 80 82 84 86 88 89 
DTAA z score -5.0 66 69 72 75 78 80 83 85 87 
DTAA z score -4.5 59 63 66 70 73 76 78 81 83 
DTAA z score -4.0 52 56 60 63 67 70 73 76 79 
DTAA z score -3.5 45 49 53 57 60 64 67 70 74 
DTAA z score -3.0 38 42 46 50 53 57 61 64 68 
DTAA z score -2.5 32 36 39 43 46 50 54 58 61 
DTAA z score -2.0 26 29 33 36 40 43 47 51 55 
DTAA z score -1.5 21 24 27 30 33 37 40 44 48 
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Table 3: Comparison of the performance of prospectively acquired fetal echocardiographic measurements 
in prediction of coarctation of aorta by receiver-operating characteristics curve analysis. [Abbreviations 








    
Variables assessed  Area under ROC curve (95% CI) P value 
Aortic valve z-score 0.570 (0.465-0.675) 0.19 
Ratio of aortic:pulmonary valve 0.653 (0.563-0.743) 0.002* 
Arterial duct  z-score (2nd trimester) 0.541 (0.414-0.668) 0.53 
DTAA z-score 0.617 (0.515-0.719) 0.03* 
Ratio of DTAA:AD (2nd trimester) 0.656 (0.539-0.773) 0.06 
DTAA:AD ratio z-score (2nd trimester) 0.656 (0.539-0.773) 0.06 
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Table 4: Sensitivity, specificity, positive predictive value and negative predictive value for distal transverse 
aortic arch z-score values. 95% confidence intervals are provided in parentheses. The false positive rate=1-
positive predictive value. 
 
 




Fishers exact   
p value 
DTAA z-score < -5 0.06 (0.02 - 0.14) 0.99 (0.92 - 1) 0. 8 (0.38 - 0.99) 0.51 (0.43 - 0.6) 0.37 
DTAA z-score < -4 0.16 (0.09 – 0.26) 0.96 (0.88 – 0.99) 0.79 (0.52 – 0.92) 0.52 (0.44 – 0.61) 0.05 
DTAA z-score < -3 0.36 (0.25 - 0.48) 0.76 (0.65 - 0.85) 0.6 (0.45 - 0.74) 0.54 (0.44 - 0.64) 0.19 
DTAA z-score < -2 0.66 (0.54 - 0.76) 0.54 (0.42 - 0.65) 0.59 (0.47 - 0.69) 0.61 (0.48 - 0.72) 0.04 
DTAA z-score < -1 0.75 (0.63 - 0.84) 0.27 (0.18 - 0.39) 0.51 (0.41 - 0.6) 0.51 (0.36 - 0.67) 0.99 
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